Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q May 16, 2022 10-Q
8-K May 3, 2022 8-K
4 Apr 28, 2022 PRIMARY DOCUMENT
8-K Apr 7, 2022 8-K
8-K Mar 31, 2022 8-K
10-K Mar 31, 2022 10-K
4 Mar 31, 2022 PRIMARY DOCUMENT
4 Mar 16, 2022 PRIMARY DOCUMENT
SC 13G/A Mar 9, 2022
4 Mar 2, 2022 PRIMARY DOCUMENT
4 Feb 23, 2022 PRIMARY DOCUMENT
8-K Feb 16, 2022 8-K
SC 13G/A Feb 14, 2022
SC 13G/A Feb 14, 2022 AMENDMENT NO. 4 TO THE SCHEDULE 13G
SC 13G/A Feb 3, 2022
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 1, 2022 PRIMARY DOCUMENT
4 Jan 26, 2022 PRIMARY DOCUMENT
SC 13G/A Jan 25, 2022 SCHEDULE 13G/A
8-K Jan 25, 2022 8-K
← Newer Page 9 of 21 · 513 filings Older →